Neumora Therapeutics is trading at $0.53, up 5.08%, on October 5, 2026; no clear company-specific announcement was found, while positive broader-market sentiment may have supported the gain. - The company’s release archive lists August 14, 2026, as its latest press release. - In the supplied market context, the S&P 500 rose 0.65% and the Nasdaq Composite gained 1.15%. No trading-volume information was provided, so activity levels cannot be assessed.